The platform provides researchers with an instantaneous view of study performance. Credit: Mdisk / Shutterstock.com. REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence ...

The company’s stock dropped by 83% after it released the data from the Phase III trial. Image credit: Eugene Mymrin / Moment via Getty Images aTyr Pharma shares plunged more than 80% after its Phase ...

PhaseV has entered into a strategic partnership with Bioforum to enhance the efficiency of clinical trials using advanced ...

Amidst significant shifts in the pharmaceutical industry, the number of clinical trials has surged over the first half of ...

The trial’s primary efficacy goal is to measure the rate of growth of atrophic lesions in the retina. Credit: SaiArLawKa2 / Shutterstock.com. Belite Bio has concluded the final participant visit in ...

These readouts will help Regeneron structure the confirmatory trials for the two allergy combination therapies.

Sanofi’s stock dropped in the wake of data from its Phase III trial of atopic dermatitis (AD) candidate amlitelimab, which ...

As the IASLC 2025 World Conference on Lung Cancer approaches, CTA looks at some of the most promising NSCLC assets in Phase ...

AstraZeneca's Tagrisso, in combination with pemetrexed and platinum-based chemotherapy, has shown a significant improvement ...

Transformative new shifts have taken place in the last month in the metabolic dysfunction-associated steatohepatitis (MASH) ...

On this episode, the healthcare editorial team unpicks several key trials and trends from this year’s event, held from 29 August to 1 September in Madrid. Data at ESC is from studies evaluating ...

Revolution will now explore daraxonrasib’s potential as a monotherapy and in combination with chemotherapy in late-stage PDAC trials.